We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sun Pharma Slapped With Warning Letter for Dadra Plant’s Multiple Violations
Sun Pharma Slapped With Warning Letter for Dadra Plant’s Multiple Violations
Multiple and repeated violations found in Sun Pharmaceuticals’ Dadra, India facility during a December 2023 FDA inspection have resulted in a Warning Letter following the company’s inadequate responses to a Form 483 levied on it earlier this year.